[1. Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among Thai adults. Obesity Res Clin Pract. 2008; 2:215-23.10.1016/j.orcp.2008.05.003362742323599834]Open DOISearch in Google Scholar
[2. World Health Organization. Cardiovascular Diseases. Geneva: World Health Organization; [cited 2009].]Search in Google Scholar
[3. Bureau of Health Policy and Plan, Office of Permanent Secretary, Ministry of Public Health. Thailand Health Profile 1997-1998. Bangkok: Printing Press, Express Transportation Organization, 2000.]Search in Google Scholar
[4. Hassinen M, Lakka TA, Komulainen P, Gylling H, Nissinen A, Rauramaa R. C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care. 2006; 29:931-2.10.2337/diacare.29.04.06.dc05-250816567842]Open DOISearch in Google Scholar
[5. Lee JG, Lee S, Kim YJ, Jin HK, Cho BM, Jeong DW, et al. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. ClinChim Acta. 2009; 408:50-5.10.1016/j.cca.2009.07.00619622349]Search in Google Scholar
[6. Okosun IS. Metabolic syndrome and C-reactive protein in American adults: the impact of abdominal obesity. Metab Syndr Relat Disord. 2008; 6:289-97.10.1089/met.2008.004019067532]Search in Google Scholar
[7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-9.10.1001/jama.287.3.35611790215]Search in Google Scholar
[8. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107:391-7.10.1161/01.CIR.0000055014.62083.05]Search in Google Scholar
[9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23:469-80.10.1111/j.1464-5491.2006.01858.x16681555]Search in Google Scholar
[10. Nash DT. Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins. J Natl Med Assoc. 2005; 97:1600-7.]Search in Google Scholar
[11. Osman R, L’Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006; 2:221-37.10.2147/vhrm.2006.2.3.221199397917326329]Search in Google Scholar
[12. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998; 98:731-3.10.1161/01.CIR.98.8.731]Open DOISearch in Google Scholar
[13. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179-86.10.1002/hep.18401205171699862]Search in Google Scholar
[14. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22:1145-58.10.1038/sj.ijo.0800770]Search in Google Scholar
[15. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19:972-8.10.1161/01.ATV.19.4.972]Search in Google Scholar
[16. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, et al. The use of highsensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008; 5: 621-35.10.1038/ncpcardio1322]Open DOISearch in Google Scholar
[17. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003; 77:379-84.10.1093/ajcn/77.2.379]Search in Google Scholar
[18. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.10.1001/jama.285.19.2486]Search in Google Scholar
[19. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropriate BMI for Asian populations. Lancet. 2004; 363:1077.10.1016/S0140-6736(04)15856-X]Search in Google Scholar
[20. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.]Search in Google Scholar
[21. Aronson D, Sella R, Sheikh-Ahmad M, Kerner A, Avizohar O, Rispler S, et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004; 44:2003-7.10.1016/j.jacc.2004.08.03015542283]Search in Google Scholar
[22. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004; 47: 1403-10.10.1007/s00125-004-1472-x15309290]Search in Google Scholar
[23. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm. 2007; 2007:93573.10.1155/2007/93573222266618288276]Search in Google Scholar
[24. Chapidze G, Dolidze N, Enquobahrie DA, Kapanadze S, Latsabidze N, Williams MA. Metabolic syndrome and C-reactive protein among cardiology patients. Arch Med Res. 2007; 38:783-8.10.1016/j.arcmed.2007.03.01117845899]Search in Google Scholar
[25. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care. 2005; 28:878-81.10.2337/diacare.28.4.87815793189]Open DOISearch in Google Scholar
[26. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004; 97:101-6.10.1016/j.ijcard.2003.08.01615336815]Search in Google Scholar
[27. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Sr., Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110:380-5.10.1161/01.CIR.0000136581.59584.0E15262834]Search in Google Scholar
[28. Yan E, Chen S, Hong K, Kim WS, Bajpai A, Treyzon L, et al. Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord. 2008; 6: 64-73.10.1089/met.2007.002718370838]Search in Google Scholar
[29. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag. 2006; 2:145-52.10.2147/vhrm.2006.2.2.145199399217319458]Search in Google Scholar